AU2776892A - Treatment of premalignant and malignant lesions - Google Patents

Treatment of premalignant and malignant lesions

Info

Publication number
AU2776892A
AU2776892A AU27768/92A AU2776892A AU2776892A AU 2776892 A AU2776892 A AU 2776892A AU 27768/92 A AU27768/92 A AU 27768/92A AU 2776892 A AU2776892 A AU 2776892A AU 2776892 A AU2776892 A AU 2776892A
Authority
AU
Australia
Prior art keywords
premalignant
treatment
malignant lesions
lesions
malignant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27768/92A
Inventor
Edmund Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Immunology Research Corp
Original Assignee
Cancer Immunology Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Immunology Research Corp filed Critical Cancer Immunology Research Corp
Publication of AU2776892A publication Critical patent/AU2776892A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
AU27768/92A 1991-10-07 1992-10-07 Treatment of premalignant and malignant lesions Abandoned AU2776892A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77241391A 1991-10-07 1991-10-07
US772413 1991-10-07

Publications (1)

Publication Number Publication Date
AU2776892A true AU2776892A (en) 1993-05-03

Family

ID=25094988

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27768/92A Abandoned AU2776892A (en) 1991-10-07 1992-10-07 Treatment of premalignant and malignant lesions

Country Status (2)

Country Link
AU (1) AU2776892A (en)
WO (1) WO1993006860A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129647A (en) * 1977-10-17 1978-12-12 Edmund Klein Treatment of acne
US4211767A (en) * 1977-10-17 1980-07-08 Edmund Klein Method of controlling the secretion of sebum in humans
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives

Also Published As

Publication number Publication date
WO1993006860A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AU674894C (en) Treatment of conditions and disease
AU2161392A (en) Methods of treating hemorrhoids and anorectal disease
AU4533593A (en) Footwear for facilitating the removal and dissipation of perspiration
AU1913792A (en) Novel derivatives of thiopyranopyrrole and preparation thereof
AU5093593A (en) Inhibition of tumor metastasis via neutralization of tissue factor function
AU6417690A (en) Topical preparation for treatment of aphthous ulcers and other lesions
HU9302347D0 (en) Application of quinones for treatment of cancer and/or aids
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU7065694A (en) Catheter and method of use thereof
AU2969597A (en) Treatment of vascular lesions
AU1097192A (en) Treatment of particulate material
AU8427091A (en) Gamma-carboxylase and methods of use
AU4133693A (en) Surface treatment of refractories
AU4678893A (en) Compositions and methods for topical treatment of skin lesions
AU7770991A (en) Method and composition for the treatment of cancer
AU1225492A (en) Process for the detection and localization of cancer
AU2776892A (en) Treatment of premalignant and malignant lesions
AU8185491A (en) Treatment of disease
AU8879691A (en) Treatment of dispersions
AU1488192A (en) Hyperpigmentation of skin
AU7167591A (en) Treatment of hsv
AU1880492A (en) Novel retro-alpha-retinol derivatives and uses of retro-alpha-retinol
AU1954492A (en) Heat treatment of bauxite
AU4319393A (en) Use of indolocarbazols in aids treatment
AU1176092A (en) Process for preparation of 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and similar compounds